Light chain proteinuria revealing mu-heavy chain disease: an atypical presentation of Waldenström macroglobulinemia in two cases.
作者信息
Vergneault Hélène, Bengoufa Djaouida, Frazier-Mironer Aline, Brocheriou Isabelle, Bitoun Samuel, Villesuzanne Camille, Talbot Alexis, Harel Stéphanie, Arnulf Bertrand, Royer Bruno
机构信息
Immuno-hematology Department, Saint-Louis Hospital, APHP, Paris.
Immunology Laboratory, Saint-Louis Hospital, APHP, Paris.
出版信息
Haematologica. 2021 Jul 1;106(7):2034-2036. doi: 10.3324/haematol.2020.277137.
Abstract
摘要
相似文献
1
Light chain proteinuria revealing mu-heavy chain disease: an atypical presentation of Waldenström macroglobulinemia in two cases.
Haematologica. 2021 Jul 1;106(7):2034-2036. doi: 10.3324/haematol.2020.277137.
2
[Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type K-paraproteinemia with plasma cell leukemia].
Schweiz Med Wochenschr. 1970 Jun 13;100(24):1012-22.
3
Discovery of a gamma heavy chain disease in a patient followed-up for a lymphoplasma cell proliferative disorder.
Ann Biol Clin (Paris). 2016 Jun 1;74(3):338-40. doi: 10.1684/abc.2016.1149.
4
[Combined features of mu-heavy chain disease and primary macroglobulinemia in a single patient: clinical and immunological studies].
Nihon Ketsueki Gakkai Zasshi. 1982 May;45(3):622-32.
5
[Heavy chain disease. Report of four cases].
Sangre (Barc). 1983;28(1):89-98.
6
7
A case of mu-heavy chain disease: combined features of mu-chain disease and macroglobulinemia.
Int J Hematol. 1997 Oct;66(3):359-65. doi: 10.1016/s0925-5710(97)00039-x.
8
Non-crystalline light chain proximal tubular disease associated with Waldenström macroglobulinemia.
Int Urol Nephrol. 2023 Feb;55(2):483-485. doi: 10.1007/s11255-022-03304-3. Epub 2022 Jul 20.
9
[Heavy chain disease. A case of IgG-heavy-chain-fragment and IgM-type-K-paraproteinemia with plasma cell leukemia].
Helv Med Acta Suppl. 1970 Jun:Suppl 50:133-4.
10
Macroglobulinemia and membranoproliferative glomerulonephritis in a hepatitis C virus-positive patient.
Clin Nephrol. 2003 Jul;60(1):49-52. doi: 10.5414/cnp60049.
本文引用的文献
1
Kidney diseases associated with Waldenström macroglobulinemia.
Nephrol Dial Transplant. 2019 Oct 1;34(10):1644-1652. doi: 10.1093/ndt/gfy320.
2
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.
3
The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia.
Clin Cancer Res. 2011 May 1;17(9):3013-8. doi: 10.1158/1078-0432.CCR-10-2954. Epub 2011 Mar 17.
4
Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemia.
Haematologica. 2008 May;93(5):793-4. doi: 10.3324/haematol.12107.
5
Mu-heavy chain disease associated with systemic amyloidosis.
Hematology. 2004 Apr;9(2):135-7. doi: 10.1080/10245330410001671561.
6
HEAVY CHAIN DISEASE- A NEW DISORDER OF SERUM GAMMA-GLOBULINS : REPORT OF THE FIRST CASE.
Am J Med. 1964 Sep;37:332-50. doi: 10.1016/0002-9343(64)90191-3.
7
Heavy chain disease.
Curr Treat Options Oncol. 2002 Jun;3(3):247-54. doi: 10.1007/s11864-002-0014-3.
8
Heavy-chain diseases.
Hematol Oncol Clin North Am. 1999 Dec;13(6):1281-94. doi: 10.1016/s0889-8588(05)70127-1.
9
Cast nephropathy in mu heavy chain disease.
Clin Nephrol. 1997 Aug;48(2):118-21.
10
Structure of abnormal heavy chains in human heavy-chain-deposition disease.
Eur J Biochem. 1995 Apr 1;229(1):54-60. doi: 10.1111/j.1432-1033.1995.tb20436.x.
Zotero 插件